Advances in psychotropic formulations
Author:
- 1 August 2006
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 30 (6) , 996-1008
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Strategies for Improving Adherence to Second-Generation Antipsychotics in Patients with Schizophrenia by Increasing Ease of UseJournal of Psychiatric Practice, 2005
- Acceptability and Disintegration Rates of Orally Disintegrating Risperidone Tablets in Patients with Schizophrenia or Schizoaffective DisorderThe Canadian Journal of Psychiatry, 2004
- Paroxetine Controlled ReleaseCNS Drugs, 2004
- Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action StudyJournal of Clinical Psychopharmacology, 2003
- A Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Selegiline Transdermal System Without Dietary Restrictions in Patients With Major Depressive DisorderThe Journal of Clinical Psychiatry, 2003
- Intramuscular Preparations of AntipsychoticsDrugs, 2003
- Transdermal Selegiline in Major Depression: A Double-Blind, Placebo-Controlled, Parallel-Group Study in OutpatientsAmerican Journal of Psychiatry, 2002
- Dissolution Profile, Tolerability, and Acceptability of the Orally Disintegrating Olanzapine Tablet in Patients with SchizophreniaThe Canadian Journal of Psychiatry, 2002
- A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in SchizophreniaArchives of General Psychiatry, 2002
- Intramuscular Ziprasidone Compared With Intramuscular Haloperidol in the Treatment of Acute PsychosisThe Journal of Clinical Psychiatry, 2000